NEW YORK — Sarepta Therapeutics became the second company in as many days to see its shares plunge as a result of a Twitter hoax on Wednesday after a user posed as an influential short-seller and alleged improprieties at the biopharmaceutical company.
Sarepta Therapeutics shares plummeted 9.9 percent in a matter of seconds after someone with the Twitter user name @citreonresearc alleged improprieties at the company.
The drop mirrored a similar incident on Tuesday, when Mountain View-basaed Audience fell more than 25 percent following tweets that at a glance looked to be from Muddy Waters, another short-selling firm.
Just as Muddy Waters confirmed it did not send such a tweet about Audience, so too did Andrew Left, the California-based investor who runs Citron, said his company did not send a message about Sarepta.
Recent Articles
-
Wecome to the ZATZ Studio
-
HTC’s HD7, the HD2 update
-
Is Windows Phone 7 for power users?
-
Open question: what would you like to see us cover?
-
Citizen journalism: is it sustainable?
-
Nik Software’s HDR Efex Pro reveals photographic details previously hidden to the naked eye
-
Status report: migrating ZENPRESS to a new platform
-
Internet Explorer 9 is out — should you download it?
From Our Sponsor
